Ichikura, Kanako
Matsuoka, Shiho
Chiba, Hiroki
Ishida, Hina
Fukase, Yuko
Murase, Hanako
Tagaya, Hirokuni
Takeuchi, Takashi
Matsushima, Eisuke
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP16J00179)
Article History
Received: 1 February 2022
Accepted: 1 March 2023
First Online: 15 March 2023
Declarations
:
: Written informed consent to participate was obtained from all the participants. They were informed about the aims of the present study and that they had the freedom to quit the survey at any time of their participation. Then, they marked a form checkbox field as a statement of consent when they returned the questionnaires. Our study was approved without undergoing assessment by the institutional review board at the Tokyo Medical and Dental University in Japan, as it was an anonymized, non-invasive, self-completed questionnaire study for health care providers. However, all procedures were in accordance with the ethical standards of the responsible committees on human experimentation (institutional and national) and with the tenets of the Helsinki Declaration of 1975, as revised in 2000.
: Not applicable.
: KI is an advisor to the development of personal health care services by Clinical Study Support, Inc. YF received research grants from the Murata Science Foundation. HT is an advisor of a clinical trial by Taisho Pharmaceutical Holdings and a committee member of the Medical Research Ethics Committee of the Nikon Corporation and the Japan Aerospace Exploration Agency. SM, HC, HI, HM, TT, and EM have no competing interests to report.